Renatus Tactical Acquisition Corp I Class A Ordinary Shares
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $325.3M
- Price
- $10.44
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.10%
- Volume
- 21.2K
About
Renatus Tactical Acquisition Corp I currently maintains no substantial business operations. The company's primary objective is to seek out and complete a strategic combination with another entity or entities, which could take the form of a merger, an exchange of shares, an asset purchase, an acquisition of equity, or a corporate reorganization. This firm was established in 2024 and is based in Coral Gables, Florida.
Quick stats
Shares outstanding31.2M
Computed float31.2M
Float / shares100.0%
Cash runway (months)-4.5
Key info
SectorFinancial Services
IndustryShell Companies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002035173
Websitehttps://www.RTAC1.com
AI Summary
AI-generated4d agominorneutralother
Complete Genomics Appoints Lauren Selig to Board of Directors
Lauren Selig, a current board member of Renatus Tactical Acquisition Corp. I (RTAC), has been appointed to the board of directors of Complete Genomics. The appointment is contingent upon the closing of Swiss Rockets AG's pending acquisition of Complete Genomics.
Selig is an entrepreneur and film producer whose credits include Academy Award-winning films, and she leads an investment fund focused on AI, space, and biotechnology. She also currently serves on the boards of XPRIZE and Pendrell.
The transaction to acquire Complete Genomics has received approval from Chinese regulators and Swiss Rockets shareholders but remains subject to CFIUS clearance.